Categories LATEST

Oracle Q1 2025 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

Software giant Oracle Corporation (NYSE: ORCL) is all set to report its first-quarter 2025 financial results today after the closing bell.


Listen to Oracle’s Q1 2025 earnings call live and read the real-time transcript


On average, analysts following the company forecast earnings of $1.32 per share, on an adjusted basis, for the first three months of fiscal 2025, which represents an 11% year-over-year increase. The consensus revenue estimate is $13.23 billion for Q1.

In the May quarter, revenues increased to $14.29 billion from $13.84 billion in the same period a year earlier. Earnings, excluding special items, were $1.63 per share in the fourth quarter, compared to $1.67 per share in the prior-year period. On an unadjusted basis, the tech firm reported a net income of $3.14 billion or $1.11 per share for Q4, compared to $3.32 billion or $1.19 per share in the corresponding period of 2024.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

GIS Earnings: All you need to know about General Mills’ Q1 2025 earnings results

General Mills, Inc. (NYSE: GIS) reported its first quarter 2025 earnings results today. Net sales decreased 1% year-over-year to $4.8 billion. Organic sales were down 1%. Net earnings attributable to

Guardian Pharmacy seeks to raise up to $108 mil in US IPO

Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to go public. In a statement filed with the Securities and

Earnings Preview: Will Micron (MU) maintain recovery momentum in Q4?

After recovering from a rough patch, Micron Technology Inc. (NASDAQ: MU) is preparing to report fourth-quarter results next week, even as the market keeps a close watch on the event

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top